Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from HUM

2 Health Insurance Stocks to Buy in October and 1 to Avoid

The raging inflation is expected to increase healthcare expenditure significantly. This, along with heightened health awareness in this post-pandemic era, should drive the demand for health insurance. So, investing in fundamentally strong health insurance stocks, UnitedHealth Group (UNH) and Humana Inc. (HUM), could be wise. On the other hand, Clover…

StockNews.com

3 Recession-Resistant Stocks to Buy in 2022

Persistent inflationary pressure and consecutive rate hikes have hit the U.S. economy’s growth prospects and raised fears of a recession. Amid this, investing in defensive stocks Coca-Cola (KO), Humana (HUM), and Casey’s General Stores (CASY) could be wise. Read on….

StockNews.com

This Is What Whales Are Betting On Humana

Someone with a lot of money to spend has taken a bearish stance on Humana (NYSE:HUM). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Worry-Free Health Care Stocks to Invest in Right Now

Amid the ongoing economic turbulence, sectors like healthcare, which enjoy inelastic demand and can pass on an increase in cost to end consumers, make a good investment option. Moreover, rising chronic diseases, an aging population, and increased healthcare spending should drive the sector’s growth. So, it could be the right…

StockNews.com

Which Health Care Stock Will Deliver Higher Returns? HUM vs. HQY

Given the inelastic demand for healthcare products and services, the sector should remain resilient amid uncertain economic conditions. Therefore, Humana (HUM) and HealthEquity (HQY) should stay afloat. But which of these stocks is a better choice for investors? Read more to find out….

StockNews.com

10 Health Care Stocks Whale Activity In Today's Session

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.

Benzinga

3 Stocks to Target as Investors Rotate Back Into the Health Care Sector

Investors seem to show renewed interest in the healthcare sector as COVID-19 cases rise worldwide and portfolio resiliency amid the uncertain macro environment. So, fundamentally strong healthcare stocks Cigna Corp (CI), Centene Corp (CNC), and Humana (HUM) might be solid buys now. Read on.

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

3 Winning Healthcare Stocks to Buy for the Rest of the Summer

Increased health awareness and the rapidly aging population are expected to drive the growth of healthcare companies. Healthcare stocks Cigna Corp. (CI), Humana (HUM), and McKesson Corp. (MCK) have bucked the market downtrend and are in momentum. Since the market is expected to remain under pressure in the near term,…

StockNews.com

Here's How Much You Would Have Made Owning Humana Stock In The Last 20 Years

Humana (NYSE:HUM) has outperformed the market over the past 20 years by 11.85% on an annualized basis producing an average annual return of 18.87%. Currently, Humana has a market capitalization of $59.29 billion.

Benzinga

What Are Whales Doing With Humana

A whale with a lot of money to spend has taken a noticeably bullish stance on Humana. Looking at options history for Humana (NYSE:HUM) we detected 10 strange trades.

Benzinga

3 Stocks That Are Thriving With Higher Rates

Rising rates are a headwind for most stocks. However, for a handful, they are leading to an earnings boom,. Here are 3 stocks benefitting from higher rates: Humana (HUM), Everest RE (RE), and Silvercrest Asset Management (SAMG).

StockNews.com

Where Humana Stands With Analysts

Humana (NYSE:HUM) has observed the following analyst ratings within the last quarter:

Benzinga

3 Defensive Stocks to Outperform in this Bear Market

While the stock market has entered a bear phase following the release of multi-decade high inflation data, the health insurance industry could survive the downturn because of the near-inelastic demand for health coverage. Therefore, investors looking to dodge a market downturn could bet on fundamentally sound health insurance stocks Anthem…

StockNews.com

If You Invested $100 In This Stock 20 Years Ago, You Would Have $2,500 Today

Humana (NYSE:HUM) has outperformed the market over the past 20 years by 10.8% on an annualized basis producing an average annual return of 17.56%. Currently, Humana has a market capitalization of $53.98 billion.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

5 Life Insurance Stocks to Buy Hand Over Fist

U.S. Treasury yields rose to multi-year highs earlier this month. And rising Treasury yields along with the Fed’s interest rate hikes bode well for life insurance companies. Thus, we think the shares of fundamentally sound life insurance companies Anthem (ANTM), Cigna Corp. (CI), UnitedHealth Group (UNH), Molina Healthcare (MOH), and…

StockNews.com

5 Outperforming Health Insurance Stocks Rated 'Strong Buy'

Demand for health insurance policies has soared over the past couple of years and is projected to continue rising amid heightened health awareness in the post-pandemic era. Thus, we think the stocks of quality health insurance companies Humana (HUM), Cigna (CI), Centene (CNC), Molina Healthcare (MOH), and Anthem (ANTM) could…

Benzinga

If You Invested $1000 In Humana 20 Years Ago, Here's How Much You Would Have Today

Humana (NYSE:HUM) has outperformed the market over the past 20 years by 10.96% on an annualized basis producing an average annual return of 17.93%. Currently, Humana has a market capitalization of $54.86 billion.

Benzinga

Expert Ratings for Humana

Over the past 3 months, 6 analysts have published their opinion on Humana (NYSE:HUM) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Humana's Return On Capital Employed Overview

According to Benzinga Pro, during Q1, Humana (NYSE:HUM) earned $930.00 million, a 7253.85% increase from the preceding quarter. Humana also posted a total of $24.08 billion in sales, a 13.59% increase since Q4.

Benzinga

Humana Q1 Earnings Beats Expectations, Raises FY22 Profit Guidance

Humana Inc (NYSE:HUM) has posted Q1 adjusted sales of $24.08 billion, beating the consensus of $23.51 billion. The benefits expense ratio increased from 86.4% to 85.9%, and the operating cost ratio increased from 12% to 9.7%. Humana posted an adjusted EPS of $8.04, beating the consensus of $6.78 and $6.38 posted a…

Benzinga

Humana: Q1 Earnings Insights

Humana (NYSE:HUM) reported its Q1 earnings results on Wednesday, April 27, 2022 at 06:30 AM. Here's what investors need to know about the announcement.

Benzinga

Humana to Offload Substantial Stake In Kindred At Home Hospice & Personal Care Divisions

Humana Inc (NYSE:HUM) has agreed to divest a majority interest in the Hospice and Personal Care divisions of Humana's Kindred at Home (KAH Hospice) subsidiary to Clayton, Dubilier & Rice (CD&R). The divisions include patient-centered services for Hospice, Palliative, Community, and Personal Care. Humana had previously indicated its intent to divest a majority…

Benzinga

If You Invested $100 In Humana 10 Years Ago, Here's How Much You Would Have Today

Humana (NYSE:HUM) has outperformed the market over the past 10 years by 5.55% on an annualized basis producing an average annual return of 18.03%. Currently, Humana has a market capitalization of $59.08 billion.

Benzinga

UBS Upgrades Rating to Buy for Humana, Raises Price Target To $520

UBS upgraded its rating of Humana (NYSE:HUM) to Buy with a price target of $520.00, changing its price target from $486.00 to $520.00. Shares of Humana are trading up 2.2% over the last 24 hours, at $458.92 per share. A move to $520.00 would account for a 13.31% increase from…

Benzinga

This Favorable Sign Appears On Humana's Chart

If history is any guide, there may be good fortune ahead for shares of Humana (NYSE:HUM). A so-called "golden cross" has formed on its chart and, not surprisingly, this could be bullish for the stock.

1 2 3 4 5

People

Dipanjan BanchurSince

722 stories

Mangeet Kaur BounsMangeet

595 stories

Jaimini DesaiJaimini

62 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.